Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Receivables (2023 - 2024)

Historic Receivables for AC Immune (ACIU) over the last 2 years, with Q4 2024 value amounting to $1.3 million.

  • AC Immune's Receivables fell 9999.24% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year decrease of 9999.24%. This contributed to the annual value of $1.3 million for FY2024, which is 9999.24% down from last year.
  • Per AC Immune's latest filing, its Receivables stood at $1.3 million for Q4 2024, which was down 9999.24% from $29.4 million recorded in Q3 2024.
  • AC Immune's Receivables' 5-year high stood at $16.7 billion during Q4 2023, with a 5-year trough of $1.3 million in Q4 2024.